dosimetry radioimmunotherapy B-cell lymphomas monoclonal antibody Sixteen patients non-Hodgkin lymphoma mCi mg radioactive iodine immunoglobulin IgG order antibody distribution pharmacokinetics dosimetry toxicity tumor targeting therapy murine monoclonal antibody MAb reactive cells non-Hodgkin B-cell lymphoma series assessable therapy patients doses small mCi IgG tumor responses partial remissions mixed minor responses response patient diagnostic doses low mCi partial remission year complete remission second low radiation dose acute toxicities myelotoxicity therapeutic doses grade IV marrow toxicity patients total doses mCi Dosimetry calculations spleen tumor dose rules cGy/mCi times dose organs administration low doses mg known extrasplenic lymphoma sites Serum clearance average distribution half-life hours elimination hours average total-body clearance hours antigenic target high amounts circulation patients injections human antimouse antibody response patients protein interesting observation study marked drop lymphocytes administration radioiodinated anticarcinoembryonic antigen MAbs nonspecific radiation effect binding MAb normal cells 